文献速递自身炎症与 IgG4 相关病其他结缔组织病

儿童A20单倍剂量不足(HA20)诊断的挑战:高度可变的临床与遗传谱

Tackling the diagnosis of HA20 in children: challenges of a highly variable clinical and genetic spectrum.
PubMed 文献 · RMD Open · 2026-02-25

该多中心回顾性队列描述了17例法国儿童期起病的HA20患者的临床、生物学和遗传特征,中位起病年龄3岁,中位诊断延迟9.7年。最常见首发表现为口腔溃疡和发热,胃肠道受累频繁;秋水仙碱单药对40%患者有效,TNF抑制剂疗效最高。结论提示对伴发热和胃肠道炎症的儿童应警惕HA20,即使无口腔/生殖器溃疡。

要点

  • 儿童HA20中位起病年龄3岁,诊断延迟可达9.7年,男孩起病和诊断更早。
  • 口腔溃疡和发热是最常见首发表现,胃肠道受累(腹痛76.5%、结肠炎35.3%)频繁。
  • TNF抑制剂疗效最高(阿达木单抗60%、英夫利西单抗100%),秋水仙碱单药对40%有效。

核心结论

  • 对伴发热和胃肠道炎症的儿童应怀疑HA20,即使无口腔或生殖器溃疡。
  • 早发性结肠炎、黏膜溃疡的特殊形态及HA20阳性家族史尤其提示本病。
  • 早期基因检测可能有助于及时诊断和靶向治疗。

研究设计与样本

  • 多中心、回顾性观察性队列研究,通过法国国家儿科风湿病网络和国家遗传性自身炎症疾病参考实验室开展。
  • 纳入17例来自11个无亲缘关系家系、起病年龄小于18岁且携带TNFAIP3突变的患者。

主要发现

  • 中位起病年龄3岁(范围1个月至17年),中位诊断延迟9.7年(范围1至43年)。
  • 男孩起病和诊断显著早于女孩。
  • 最常见首发表现为口腔溃疡(64.7%)、发热(64.7%)、腹痛(47.1%)、关节痛(35.3%)和皮疹(17.6%)。
  • 生殖器溃疡起病时占17.6%,随访期间达52.9%;胃肠道受累常见(腹痛76.5%、结肠炎35.3%)。
  • 其他表现包括关节痛(52.9%)、关节炎(29.4%)、皮疹(41.2%)、淋巴结肿大(35.3%)、肝大(11.8%)、头痛(17.6%)和葡萄膜炎(5.9%);发作期CRP显著升高;发现3个新TNFAIP3变异。

关键数值与推荐

  • 秋水仙碱单药治疗对40%患者有效。
  • TNF抑制剂疗效最高:阿达木单抗60%有效,英夫利西单抗100%有效。

临床怎么用

  • 对不明原因发热伴胃肠道炎症的儿童,即使无口腔/生殖器溃疡,也应将HA20纳入鉴别诊断。
  • 关注早发性结肠炎、黏膜溃疡特殊形态及HA20家族史,尽早进行TNFAIP3基因检测。
  • 治疗上可考虑TNF抑制剂(阿达木单抗、英夫利西单抗),秋水仙碱可作为部分患者的单药选择。

局限性

  • 回顾性观察性设计,样本量小(17例),可能存在选择偏倚和随访数据不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the clinical, biological and genetic characteristics of paediatric-onset A20 haploinsufficiency (HA20) and to identify key clinical features that may guide early diagnosis and management. METHODS: Multicentre, retrospective observational cohort study through the French national paediatric rheumatology network and national reference laboratories for genetic autoinflammatory diseases. 17 patients from 11 unrelated families, with disease onset before 18 years of age and carrying a tumour necrosis factor alpha-induced protein 3 (TNFAIP3) mutation, were included. RESULTS: Median age at symptom onset was 3 years (range: 1 month-17 years) with a median diagnostic delay of 9.7 years (range: 1-43 years). Boys had a significantly earlier onset and diagnosis than girls. The most common initial manifestations were oral ulcers (64.7%), fever (64.7%), abdominal pain (47.1%), arthralgia (35.3%) and skin eruption (17.6%). Genital ulcers occurred in 17.6% at onset but in 52.9% during follow-up. Gastrointestinal involvement was frequent (abdominal pain in 76.5% of patients and colitis in 35.3%). Other features included arthralgia (52.9%), arthritis (29.4%), skin eruption (41.2%), lymphadenopathy (35.3%), hepatomegaly (11.8%), headache (17.6%) and uveitis (5.9%). C reactive protein (CRP) levels were significantly higher during flares. Three novel TNFAIP3 variants were identified. Colchicine was effective as monotherapy in 40%. TNF-inhibitors showed the highest efficacy (adalimumab 60%, infliximab 100%). CONCLUSIONS: HA20 should be suspected in children with fever and gastrointestinal inflammation, even in the absence of oral/genital ulcers. Early onset colitis, the distinctive morphology of mucosal ulcers and a positive family history for HA20 are particularly suggestive. Early genetic testing may enable prompt diagnosis and targeted therapy.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Anselmi F, Frémond ML, Remaux H, et al. Tackling the diagnosis of HA20 in children: challenges of a highly variable clinical and genetic spectrum. RMD Open. 2026. PMID: 41741169. doi:10.1136/rmdopen-2025-006379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。